Riskpilot← Back to searchSign inGet full accessHEBERO AS
ASActiveOrg 997648110Storgata 2D, 4790 LillesandGeneral medical practice activities · NACE 8621Est. 20110 employees
Revenue 2024
NOK 0
EBITDA margin
—
+31% vs 2023
Equity ratio
89.5%
Financial strength
Net profit 2024
NOK 7,3M
-32% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -18K | +31% |
| Net profit | NOK 7,3M | -32% |
| Total assets | NOK 31,9M | +12% |
| Equity | NOK 28,6M | +23% |
| Employees | 0 | — |
Legal name
HEBERO AS
Org number
997648110
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. november 2011
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Holdingselskap, eie, omsetning og investeringer i aksjer i andre selskaper, legevirksomhet med alt dette tilhører, samt å delta i andre virksomheter i samme eller lignende bransjer.
Address
Storgata 2D, 4790 Lillesand
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −29 | −24 | −35 | −26 | −18 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −29 | −24 | −35 | −26 | −18 |
| Net financials | 4 751 | 4 500 | 4 699 | 11 953 | 8 609 |
| Profit before tax | 4 722 | 4 476 | 4 664 | 11 927 | 8 591 |
| Tax | 1 007 | 985 | 1 180 | 1 198 | 1 325 |
| Net profit | 3 714 | 3 491 | 3 484 | 10 729 | 7 266 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 162 | 18 750 | 17 812 | 28 523 | 31 918 |
| Equity | 11 106 | 13 097 | 16 581 | 23 310 | 28 576 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 056 | 5 653 | 1 231 | 5 213 | 3 343 |
| Total debt | 1 056 | 5 653 | 1 231 | 5 213 | 3 343 |
EBITDA margin
-1800000.0%
This company
15.8%
Market median
-11392505% vs market
20202024
Equity ratio
89.5%
This company
38.2%
Market median
+134% vs market
20202024
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
726597700.0%
This company
8.1%
Market median
+8970341875% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JR Deputy Member | Deputy Member | 2011 |
HC Chief Executive Officer | Chief Executive Officer | 2011 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HEBERO AS 
AGDER LUNGE OG ALLERGI SENTER ASBoard members of HEBERO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jürgen Rolke | Deputy Member | 0 companies |
| Heidi Cathrine Berg Rolke | Chief Executive Officer | 0 companies |